Researchers have developed a breakthrough blood test capable of identifying Sjogren's syndrome markers up to a decade before clinical manifestations emerge. This autoimmune disorder, predominantly affecting women, impacts approximately 500,000 people across the UK. Early detection through biomarker screening offers significant potential for intervention strategies and disease management, potentially transforming patient outcomes by enabling preventative treatment approaches before symptoms become apparent.

Summary auto-generated by AI from the original publisher's content. Editorial standards.